Thyrocare Technologies' Q2 FY 2025-26 Quarterly Results

Result Summary

• Thyrocare Technologies Ltd reported a 11.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 22.0%.
• Its expenses for the quarter were up by 6.7% QoQ and 10.1% YoY.
• The net profit increased 24.9% QoQ and increased 81.0% YoY.
• The earnings per share (EPS) of Thyrocare Technologies Ltd stood at 9.03 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Thyrocare Technologies Ltd is a prominent player in the diagnostic and healthcare services industry, primarily known for providing diagnostic laboratory services. The company specializes in preventive and wellness health checkups, with a wide range of tests and diagnostics offered through its network of laboratories across India. Thyrocare has established itself as a leader in its sector, focusing on affordable, quality healthcare services. While no recent major developments are provided in the data, Thyrocare continues to be recognized for its extensive service offerings and technological integration in healthcare diagnostics.

Revenue

In the second quarter of the fiscal year 2026, Thyrocare Technologies Ltd reported a total income of ₹219.58 crores. This represents a significant increase compared to the previous quarter (Q1FY26) and the same quarter of the previous year (Q2FY25). Specifically, the quarter-over-quarter (QoQ) growth in total income was 11.1%, while the year-over-year (YoY) growth was 22.0%. This upward trend in revenue indicates a strong performance over the analyzed periods, reflecting an increase in demand or improved service offerings in the market.

Profitability

Profitability metrics for Thyrocare Technologies Ltd reveal a positive trajectory with substantial growth in profits before and after tax. The Profit Before Tax (PBT) for Q2FY26 stood at ₹62.30 crores, showing a robust quarter-over-quarter growth of 24.0% and an impressive year-over-year increase of 68.1%. After accounting for taxes, the Profit After Tax (PAT) was ₹47.81 crores, marking a QoQ growth of 24.9% and an YoY growth of 81.0%. Earnings per share (EPS) also rose from ₹7.33 in Q1FY26 to ₹9.03 in Q2FY26, highlighting a 23.2% QoQ increase and an 81.3% YoY increase, indicating strong profitability improvements.

Operating Metrics

Thyrocare Technologies Ltd's operating metrics reflected in the report indicate an increase in both income and expenses. Total expenses for Q2FY26 were recorded at ₹157.28 crores, which is a 6.7% rise from the preceding quarter and a 10.1% increase from the same quarter in the previous year. The tax expense for the quarter was ₹14.77 crores, showing a QoQ increase of 21.2% and a YoY increase of 42.7%. These figures suggest an expansion in operational activities, contributing to the company's overall financial growth. The significant rise in profits despite increased expenses indicates effective cost management and operational efficiency.